Bessemer Group Inc. Purchases 35,640 Shares of The Cooper Companies, Inc. $COO

Posted by on Jul 18th, 2026

Bessemer Group Inc. grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 3.9% during the first quarter, according to its most recent filing with the SEC. The firm owned 944,074 shares of the medical device company’s stock after acquiring an additional 35,640 shares during the period. Bessemer Group Inc.’s holdings in Cooper Companies were worth $67,502,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after buying an additional 7,363 shares during the period. First Trust Advisors LP lifted its position in Cooper Companies by 115.8% during the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock valued at $9,702,000 after acquiring an additional 73,165 shares during the period. Cresset Asset Management LLC purchased a new position in Cooper Companies during the 2nd quarter valued at about $291,000. Cerity Partners LLC boosted its stake in Cooper Companies by 4.4% during the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after acquiring an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. boosted its stake in Cooper Companies by 2.8% during the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after acquiring an additional 973 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 1.9%

Shares of Cooper Companies stock opened at $71.71 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock has a market capitalization of $13.99 billion, a PE ratio of 60.77, a price-to-earnings-growth ratio of 1.91 and a beta of 0.84. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The company has a 50-day simple moving average of $66.24 and a two-hundred day simple moving average of $72.58.

Cooper Companies (NASDAQ:COO – Get Free Report) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the firm posted $0.96 earnings per share. The business’s revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on COO. JPMorgan Chase & Co. decreased their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Robert W. Baird dropped their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research report on Friday, June 5th. Stifel Nicolaus cut their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Needham & Company LLC reduced their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Finally, The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research note on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $81.85.

Get Our Latest Analysis on Cooper Companies

Cooper Companies Company Profile

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Read More

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.